Epidemiology of transient ischemic attack and ischemic stroke in patients with underlying cardiovascular disease

Philip B. Gorelick*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

It is estimated that 15 to 30% of ischemic strokes are cardioembolic in origin, and that atrial fibrillation, valvular heart disease, coronary artery disease, congestive heart failure, and myocardial infarction are significant risk factors for stroke, which underscores the importance for cardiologists to understand this condition. The high incidence and substantial cost of stroke justify aggressive treatment of stroke risk factors, especially in the elderly, diabetic, and black populations, and in patients who have had an initial stroke. Antiplatelet therapy and administration of oral anticoagulants have both been shown to have a substantial impact on stroke in specified populations at risk.

Original languageEnglish (US)
Pages (from-to)II4-II11
JournalClinical Cardiology
Volume27
Issue number5 SUPPL. 2
DOIs
StatePublished - May 2004

Keywords

  • Antiplatelets
  • Cardiovascular disease
  • Cerebrovascular event
  • Stroke
  • Stroke epidemiology
  • Stroke risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Epidemiology of transient ischemic attack and ischemic stroke in patients with underlying cardiovascular disease'. Together they form a unique fingerprint.

Cite this